Paratesticular Liposarcoma: What is the Best Therapeutic Strategy? by Makni, A et al.
African Journal of Urology
1110-5704
Vol. 17, No. 2, 2011
56
      56-58
Case Report Paratesticular Liposarcoma: What is the Best 
Therapeutic Strategy?
A. Makni1, W. Rebai1, H. Azzouz3, Y Nouira2, H. Magherbi1, M. Jouini1, 
M. Kacem1, Z. Ben Safta1
Departments of 1General Surgery (A), 2Urology, 3Anatomopathology, 
La Rabta Hospital, Tunis, Tunisia
ABSTRACT
Introduction: Liposarcomas are neoplasms of mesodermal origin derived from adipose tissue 
and correspond to 10–14% of all soft tissue sarcomas. Paratesticular liposarcoma is very rare. 
Case report: We report a 60-year old man who presented with a left testicular tumor 20 cm in 
diameter. Initial incisional biopsy was reported as fibromatosis. Chest and abdominal CT scan 
did not show distant metastases. Through an inguinal incision orchidectomy with homolateral 
inguinal node dissection was performed. Histopathological examination showed a paratesticular 
myxoid liposarcoma. Adjuvant radiotherapy without chemotherapy was administered. The 
patient remains well at 11 months followup, with no evidence of recurrence.
Conclusion: Complete surgical extirpation reduces the risk of local recurrence. Neoadjuvant 
chemotherapy or radiotherapy may reduce the tumor size, thus facilitating complete excision.
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INTRODUCTION                                                    
Paratesticular myxoid liposarcoma is a 
rare tumor which includes all liposarcomas 
arising in the structures around the testis, 
including the lower end of the spermatic 
cord1,2. Radical orchidectomy is the 
recommended therapy1-3. Radiotherapy 
may be considered in intermediate or high-
grade tumors and recurrent liposarcomas2. 
The role of chemotherapy remains unclear.
OBSERVATION                                             
A 60-year-old man presented with a 
painless left inguinoscrotal swelling which 
had slowly increased in size over two 
years. The size had increased suddenly in 
preceding 6 weeks. On examination there 
was a firm, painless mass 20 cm in longest 
diameter in the left scrotal-inguinal region. 
The left testicle could not be identified. The 
right testis and spermatic cord were normal. 
Abdominal ultrasonography, abdominal 
Computed Tomography (CT) and chest 
ultrasonography did not show distant 
metastases. Through an inguinal incision, 
orchidectomy with homolateral inguinal 
node dissection was performed (Fig. 1). 
Histopathological examination revealed 
a paratesticular myxoid liposarcoma 
(Fig. 2). Adjuvant radiotherapy without 
chemotherapy was administered. The patient 




Figure 1: Surgical specimen consisting of a large tumor 
adjacent to the left testicle.
DISCUSSION                                                 
Liposarcomas are soft tissue sarcomas 
that originate from adipose tissue. These 
tumors represent lesser than 1% of 
all malignant tumors4, 5. Paratesticular 
liposarcoma has been rarely reported in the 
literature1-3. In the retrospective study 
of 30 cases of paratesticular liposarcoma 
reported by Montgomery et al, the average 
patient age was 63 years, the average tumor 
size was 11 cm and only one patient had 
a myxoid type liposarcoma1. Our patient 
who was 60-years old at presentation had 
a testicular tumor of 20 cm in diameter 
which was a myxoid liposarcoma. 
Complete surgical resection through 
an inguinal incision offers the best 
chance of cure and prevention of local 
recurrence3, 6, 7. However, orchidectomy via 
transscrotal incision is to be condemned 
because it risks the implantation of 
neoplastic cells in the scrotal skin, thus 
increasing the potential area of lymph 
node metastases.
Mesodermal tumors in general and 
liposarcomas in particular are known to 
be radioresistant and chemoresistant8. 
However, radiation has shown favorable 
results in some studies9. For this reason we 
used adjuvant radiotherapy in our patient. 
It is not known whether neoadjuvant 
chemotherapy could reduce tumor bulk, 
thus facilitating subsequent surgical 
excision.
In a study of 22 genitourinary sarco-
mas published by Mondaini et al3, ad-
verse prognostic factors were testicular 
location of the tumor, size exceeding 5 
cm and poor histological differentiation. 
CONCLUSION                                              
Paratesticular myxoid liposarcoma is a 
rare tumor. The best treatment is radical 
orchidectomy with wide margins through 
an inguinal incision. The value of adju-
vant radiotherapy and chemotherapy re-
mains unproven.
Figure 2: Histopathological examination.
Above: The stroma shows a characteristic plexiform 
arrangement of capillaries as well as abundant myxomatous 
matrix. (HE x 40).
Below: Higher magnification shows high mitotic activity 
with numerous abnormal nuclei. Many cells are lipoblasts 
containing cytoplasmic lipid vacuoles which indent the 
nucleus or displace it to an ezccentric position (HE x 200).
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